Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.09
-0.03 (-0.49%)
At close: Apr 28, 2026, 4:00 PM EDT
6.22
+0.13 (2.13%)
After-hours: Apr 28, 2026, 4:19 PM EDT
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 435 employees as of December 31, 2025. The number of employees increased by 41 or 10.41% compared to the previous year.
Employees
435
Change (1Y)
41
Growth (1Y)
10.41%
Revenue / Employee
$670,908
Profits / Employee
$1,274
Market Cap
1.05B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| KalVista Pharmaceuticals | 275 |
| Xencor | 260 |
| Geron | 258 |
| uniQure | 221 |
| Omeros | 175 |
| Zenas BioPharma | 167 |
| Septerna | 130 |
| ORIC Pharmaceuticals | 104 |
XERS News
- 5 days ago - Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
- 25 days ago - Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Xeris Biopharma Holdings Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 2 months ago - Xeris Biopharma Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance - Business Wire
- 2 months ago - Why Are Shares Of Xeris Biopharma Falling Friday? - Benzinga
- 2 months ago - Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit - Business Wire
- 2 months ago - Xeris Biopharma to Report Full Year 2025 Financial Results and Provide Full Year 2026 Guidance on March 2, 2026 - Business Wire